Eulerpool Terminal
The edge that pays for itself.
Current eFFECTOR Therapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
11.22 USD
+5,609,900.14 %
Median
11.22 USD
+5,609,900.14 %
Max
12.60 USD
Min
10.10 USD
Last Price
0.00 USD
Buy
7
Hold
1
Sell
0
The average target price for eFFECTOR Therapeutics is 11.22 USD. (+5,609,900.14 % above the current price)
The median price target of eFFECTOR Therapeutics is 11.22 USD.
Stock analysts from many renowned investment banks are closely examining the eFFECTOR Therapeutics stock. They conclude their professional eFFECTOR Therapeutics stock analyses with a clear recommendation for the eFFECTOR Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2024-10-01 | 7 | 1 | 0 | — |
| 2024-09-01 | 7 | 1 | 0 | — |
| 2024-08-01 | 7 | 1 | 0 | — |
| 2024-07-01 | 7 | 1 | 0 | 11.22 USD |
| 2024-06-01 | 7 | 1 | 0 | 11.22 USD |
| 2024-05-01 | 7 | 1 | 0 | 11.22 USD |
eFFECTOR Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for eFFECTOR Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2027e | 76.00 M USD | — | — |
| 2028e | 213.00 M USD | — | — |
| 2029e | 341.00 M USD | — | — |